[1] 闫道普,孙宁. 中西医结合治疗脂肪性肝病的认识与思考.中国新药杂志,2011,20(22):32-35. [2] Targher,GF,Marchesini MG. Increased risk of cardiovascular disease in non-alcoholic fatty liver disease:causal effect or epiphenomenon. Diabetologia,2008,51 (11):1947-1953 [3] Tokushige K,Hashimoto E,Noto H,et al. Influence of adiponectin gene polymorphisms in Japanese patients with non-alcoholic fatty liver disease. J Gastroenterol. 2009,44 (9):976-982. [4] 智陛雯,赵龙凤,王艳. TGF-β509C/T位点基因多态性与非酒精性脂肪肝病的关系. 中国医疗前沿,2011,1(6):33-34. [5] 赖晓波,聂玉强,李瑜元,等. 非酒精性脂肪肝患者瘦素基因G2548A位点多态性与胰岛素抵抗的关系-附107例报告. 新医学,2008,39(12):781-782. [6] Yang ZT,Zhang XX,Kong XF,et al. Polymorphisms of microsomal triglyceride transfer protein in different hepatitis B virus-infected patients. World J Gastroenterol. 2008,14(35):5454-5460. [7] 叶晓光,廖云珍. 肝病患者血清当中TFGα含量与肝功能的关系研究. 临床肝胆病杂志,2001,17(5):83-84. [8] 吕小平,詹灵凌. 慢性肝病患者血清TFG-α和TGF-β的检测及意义. 广州医科大学学报,2002,19(5):626-627. [9] Hajiaghamohammadi AA,Ziaee A,Samimi R. The efficacy of licorice root extract in decreasing transaminase activities in non-alcoholic fatty liver disease:A randomized controlled clinical trial. Phytother Res,2012,26(9):1381-1384. [10] 倪培华,应雅韵,张洁,等. 肝脂酶启动子250G/A多态性与血脂的关系. 检验学,2005,6(20):565-567. [11] Golbidi S,Laher I,Magri CJ. Exercise induced adipokine changes and the metabolic syndrome. J Diabetes Res,2014:726861. [12] Liu S,Wu HJ,Zhang ZQ,et al. The ameliorating effect of rosiglitazone on experimental nonalcoholic steatohepatitis is associated with regulating adiponectin receptor expression in rats. Eur J Pharmacol,2010,650(1):384-389. [13] Giby VJ, Ajith TA. Role of adipokines and peroxisome proliferator-activated receptors in nonalcoholic fatty liver disease.World J Hepatol,2014,6(8):570-579. [14] Wang C,Yan Y,Hu L,et al. Rapamycin-mediated CD36 translational suppression contributes to alleviation of hepatic steatosis. Biochem Biophy Res Commun,2014,447(1):57-63. [15] Soresi M,Noto D,Alberto AB,et al. Nonalcoholic fatty liver and metabolic syndrome in Italy:results from a multicentric study of the Italian Arteriosclerosis society.Acta Diabetologica,2013,(2):241-249. [16] 刘益娟. 非酒精性脂肪肝患者发生2型糖尿病危险因素分析及脂肪肝的程度与血糖控制情况的相关性研究.福建医科大学学报,2010,23:142-146. [17] 朱立红,倪培华,应雅韵,等. 血脂与肝脂酶启动子514C/T多态性的关系. 诊断学理论与实践,2005,4:439. [18] Anty R,Marjoux S,Tran A. Regular coffee but not express of drinking is protective against fibrosis in a cohort mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgery. J Hepatol,2012,57(5):1090-1096. [19] Torres DM,Williams CD,Harrison SA. Features,diagnosis,and treatment of nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol,2012,10(8):837-858. [20] Nseir W,Mograbi J,Ghali J. Lipid-lowering agents in nonalcoholic fatty liver disease and steatohepatitis:Human studies. Dig Dis Sci,2012,57(7):1773-1778. [21] He XP,Xu XW,Zhao SH,et al. Investigation of leptin1 as a candidate gene for fat deposition in pigs. Mol Biol Rep,2009,36(5):1175-1180. |